Imagion Biosystems Ltd. (AU:IBX) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Imagion Biosystems Ltd. has announced a significant change in the interests of its director, Brett Mitchell, with the acquisition of 3.75 million ordinary shares and 1.875 million unlisted options. The transaction, valued at $75,000 for the shares, reflects a strategic move by Mitchell, potentially indicating confidence in the company’s future growth.
For further insights into AU:IBX stock, check out TipRanks’ Stock Analysis page.